|
⚲
|
| Keyboard |
| Snyder Mark Howard
✚
|
|
|---|---|
| CIK # | 0001902866 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001902866] | |
| 4 | [0001902866] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Snyder Mark Howard | |
| Halozyme Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-02-23 | Option exercise | 7,011 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-02-23 | Tax withheld | 3,782 | $70.64 | 267,160 |
|
Halozyme Therapeutics Inc HALO
Restricted Stock Units · derivative
|
2026-02-23 | Option exercise | 7,011 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-02-20 | Tax withheld | 2,876 | $70.98 | 204,138 |
|
Halozyme Therapeutics Inc HALO
Restricted Stock Units · derivative
|
2026-02-20 | Option exercise | 5,332 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-02-20 | Option exercise | 5,332 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Performance Stock Units · derivative
|
2026-02-16 | Option exercise | 12,016 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Restricted Stock Units · derivative
|
2026-02-16 | Option exercise | 4,796 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-02-16 | Option exercise | 12,016 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-02-16 | Tax withheld | 2,587 | $79.44 | 205,511 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-02-16 | Tax withheld | 6,481 | $79.44 | 514,851 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-02-16 | Option exercise | 4,796 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Restricted Stock Units · derivative
|
2026-02-09 | Grant | 17,396 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Performance Stock Units · derivative
|
2026-02-09 | Grant | 29,502 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Option to Purchase Common Stock · derivative
|
2026-02-09 | Grant | 18,730 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Performance Stock Units · derivative
|
2026-02-09 | Grant | 7,808 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Performance Stock Units · derivative
|
2026-02-09 | Grant | 4,651 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-01-03 | Tax withheld | 4,243 | $70.31 | 298,325 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-01-03 | Option exercise | 7,611 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Restricted Stock Units · derivative
|
2026-01-03 | Option exercise | 7,611 | $0.00 | |
| showing 20 of 57 most recent transactions | |||||